Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02711670 · ClinicalTrials.gov registry record · NA

Night Time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium

A NA study of Kidney Stones, sponsored by VA New York Harbor Healthcare System.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT02711670 is a NA study of Kidney Stones that has completed, run by VA New York Harbor Healthcare System. The registered enrollment target is 10 participants, below the 294-participant average among 15 other Kidney Stones trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02711670, a NA study of Kidney Stones, has completed, sponsored by VA New York Harbor Healthcare System.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Thiazide diuretics will be more effective in lowering urine calcium excretion if taken at night as compared to the daytime. It will therefore be more effective in reducing kidney stone recurrence in nephrolithiasis patients with elevated urine calcium who are known to have increased risk of kidney stones at night time.

Conditions Studied

Kidney Stones

Interventions

  • DRUG chlorthalidone
  • DRUG Hydrochlorothiazide

Study Locations (1)

New York

  • VA New York Harbor Healthcare System - New York

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-02
Est. Completion 2017-06
Phase NA

Sponsor

VA New York Harbor Healthcare System

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02711670

The ClinicalTrials.gov registry entry for NCT02711670 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 294-participant average among 15 other Kidney Stones trials with a reported enrollment target (97% lower). The listed sponsor is VA New York Harbor Healthcare System, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Kidney Stones appearing as the primary indexed condition, and to 2 interventions - of which chlorthalidone is the first listed.

NCT02711670 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02711670 about?

NCT02711670 is a clinical study titled "Night Time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium". Thiazide diuretics will be more effective in lowering urine calcium excretion if taken at night as compared to the daytime. It will therefore be more effective in reducing kidney stone recurrence in nephrolithiasis patients with elevated urine calcium who are known to have increased risk of kidney s...

What is the current status of trial NCT02711670?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-02. Estimated completion is 2017-06.

What conditions does trial NCT02711670 study?

This clinical trial studies the following conditions: Kidney Stones.

What interventions are being tested in trial NCT02711670?

The interventions under investigation include: chlorthalidone (DRUG), Hydrochlorothiazide (DRUG).

Who is sponsoring clinical trial NCT02711670?

This trial is sponsored by VA New York Harbor Healthcare System, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02711670 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Kidney Stones

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Kidney Stones

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.